Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (937) 937
science & technology (833) 833
life sciences & biomedicine (794) 794
female (563) 563
male (534) 534
aminoquinolines - therapeutic use (524) 524
aminoquinolines - adverse effects (513) 513
aminoquinolines - administration & dosage (450) 450
dermatology (439) 439
imiquimod (402) 402
biological and medical sciences (348) 348
medical sciences (344) 344
middle aged (343) 343
adult (325) 325
treatment outcome (284) 284
aged (268) 268
administration, topical (246) 246
skin neoplasms - drug therapy (234) 234
animals (207) 207
antineoplastic agents - administration & dosage (176) 176
antineoplastic agents - therapeutic use (172) 172
pharmacology. drug treatments (159) 159
adjuvants, immunologic - administration & dosage (144) 144
adjuvants, immunologic - therapeutic use (144) 144
antineoplastic agents - adverse effects (143) 143
adjuvants, immunologic - adverse effects (142) 142
aminoquinolines - pharmacology (135) 135
care and treatment (135) 135
aged, 80 and over (122) 122
administration, cutaneous (120) 120
carcinoma, basal cell - drug therapy (120) 120
mice (108) 108
skin neoplasms - pathology (107) 107
infectious diseases (103) 103
adolescent (102) 102
drug therapy (90) 90
double-blind method (85) 85
drug administration schedule (85) 85
dose-response relationship, drug (84) 84
cancer (83) 83
follow-up studies (83) 83
abridged index medicus (82) 82
pharmacology & pharmacy (82) 82
condylomata acuminata - drug therapy (77) 77
ointments (76) 76
research (75) 75
tumors of the skin and soft tissue. premalignant lesions (74) 74
immunology (71) 71
dosage and administration (68) 68
analysis (66) 66
malaria (63) 63
skin (63) 63
skin cancer (63) 63
surgery (62) 62
antibiotics. antiinfectious agents. antiparasitic agents (60) 60
carcinoma, basal cell - pathology (60) 60
disease models, animal (57) 57
keratosis, actinic - drug therapy (57) 57
child (55) 55
oncology (55) 55
keratosis - drug therapy (54) 54
psoriasis (54) 54
time factors (54) 54
young adult (53) 53
antimalarials - adverse effects (51) 51
interferon inducers - therapeutic use (51) 51
aminoquinolines - pharmacokinetics (49) 49
health aspects (49) 49
prospective studies (49) 49
skin - pathology (49) 49
actinic keratosis (48) 48
medicine & public health (48) 48
basal cell carcinoma (47) 47
combined modality therapy (47) 47
interferon inducers - adverse effects (47) 47
photochemotherapy (44) 44
aminoquinolines (43) 43
carcinoma, squamous cell - drug therapy (43) 43
prolactin - blood (43) 43
clinical trials (42) 42
immunotherapy (41) 41
inflammation (41) 41
interferon inducers - administration & dosage (41) 41
psoriasis - chemically induced (41) 41
general & internal medicine (40) 40
parasitic diseases (40) 40
aminoquinolines - chemistry (39) 39
antimalarials - therapeutic use (39) 39
antiviral agents (39) 39
randomized controlled trials as topic (39) 39
tumors (39) 39
child, preschool (38) 38
dopamine agonists - therapeutic use (38) 38
fluorouracil - therapeutic use (38) 38
medicine, general & internal (38) 38
mice, inbred c57bl (37) 37
endocrinology & metabolism (36) 36
pituitary neoplasms - drug therapy (36) 36
psoriasis - pathology (36) 36
viral diseases (36) 36
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1030) 1030
French (14) 14
Spanish (9) 9
German (8) 8
Russian (7) 7
Japanese (3) 3
Portuguese (3) 3
Bulgarian (1) 1
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges
by Trace, Anthony P and Enos, Clinton W and Mantel, Alon and Harvey, Valerie M
American journal of clinical dermatology, ISSN 1175-0561, 06/2016, Volume 17, Issue 3, pp. 201 - 223
Life Sciences & Biomedicine | Dermatology | Science & Technology | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Adjuvants, Immunologic - administration & dosage | Cell Proliferation | Fibroblasts - physiology | Keloid - etiology | Humans | Aminoquinolines - administration & dosage | Antibiotics, Antineoplastic - adverse effects | Antimetabolites - therapeutic use | Cicatrix, Hypertrophic - pathology | Adjuvants, Immunologic - adverse effects | Fluorouracil - therapeutic use | Inflammation - metabolism | Anti-Inflammatory Agents - adverse effects | Fluorouracil - administration & dosage | Bleomycin - therapeutic use | Fluorouracil - adverse effects | Extracellular Matrix - physiology | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Laser Therapy - methods | Adjuvants, Immunologic - therapeutic use | Glucocorticoids - adverse effects | Cicatrix, Hypertrophic - etiology | Keloid - pathology | Keloid - therapy | Clinical Trials as Topic | Bleomycin - administration & dosage | Bleomycin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Antimetabolites - administration & dosage | Antimetabolites - adverse effects | Collagen - metabolism | Antibiotics, Antineoplastic - therapeutic use | Cicatrix, Hypertrophic - therapy | Combined Modality Therapy - methods | Wound Healing - physiology | Cryotherapy - methods | Aminoquinolines - therapeutic use | Aminoquinolines - adverse effects
Journal Article
Details down arrow
2. Full Text Pharmacokinetic interactions between tafenoquine and dihydroartemisinin-piperaquine or artemether-lumefantrine in healthy adult subjects
by Green, Justin A and Mohamed, Khadeeja and Goyal, Navin and Bouhired, Samia and Hussaini, Azra and Jones, Siôn W and Koh, Gavin C. K. W and Kostov, Ivan and Taylor, Maxine and Wolstenholm, Allen and Duparc, Stephan
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 12/2016, Volume 60, Issue 12, pp. 7321 - 7332
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Ethanolamines - adverse effects | Artemisinins - pharmacokinetics | Humans | Middle Aged | Half-Life | Male | Healthy Volunteers | Quinolines - pharmacokinetics | Young Adult | Ethanolamines - pharmacokinetics | Drug Interactions | Adult | Female | Fluorenes - adverse effects | Drug Therapy, Combination | Antimalarials - adverse effects | Fluorenes - pharmacokinetics | Antimalarials - pharmacokinetics | Plasmodium vivax - drug effects | Malaria, Vivax - drug therapy | Adolescent | Aged | Aminoquinolines - pharmacokinetics | Artemisinins - adverse effects | Quinolines - adverse effects | Aminoquinolines - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
by Patil, Vaishali M and Singhal, Shipra and Masand, Neeraj
Life sciences (1973), ISSN 0024-3205, 08/2020, Volume 254, pp. 117775 - 10
COVID-19 | Anti-viral mechanism | Hydroxychloroquine | Safety | Chloroquine | Aminoquinolines | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hydroxychloroquine - therapeutic use | Pandemics | Antiviral Agents - therapeutic use | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Betacoronavirus - drug effects | Chloroquine - therapeutic use | Treatment Outcome | Clinical Trials as Topic | Drug Repositioning | Hydroxychloroquine - adverse effects | Chloroquine - adverse effects | Randomized Controlled Trials as Topic | SARS-CoV-2 | Antiviral Agents - adverse effects | Aminoquinolines - therapeutic use | Aminoquinolines - adverse effects | Antiviral agents | Side effects | Toxicity | Viral diseases | Clinical trials | Coronaviruses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A randomised study of topical 5 imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up
by Krawtchenko, N and Roewert-Huber, J and Ulrich, M and Mann, I and Sterry, W and Stockfleth, E
British journal of dermatology (1951), ISSN 0007-0963, 12/2007, Volume 157, Issue s2, pp. 34 - 40
5-fluorouracil | actinic keratoses | comparative study | cryosurgery | imiquimod | field cancerisation | 5‐fluorouracil | Field cancerisation | 5-Fluorouracil | Cryosurgery | Actinic keratoses | Imiquimod | Comparative study | Life Sciences & Biomedicine | Dermatology | Science & Technology | Neoplasms, Radiation-Induced - surgery | Skin Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Keratosis - drug therapy | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Immunocompetence | Skin Neoplasms - surgery | Esthetics | Treatment Outcome | Neoplasms, Radiation-Induced - drug therapy | Ultraviolet Rays - adverse effects | Carcinoma, Squamous Cell - drug therapy | Aged | Cryosurgery - adverse effects | Aminoquinolines - therapeutic use | Aminoquinolines - adverse effects | Medical research | Algorithms | Surgery | Patient outcomes | Medicine, Experimental | Comparative analysis | Fluorouracil | Keratosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis
by Satake, Kyosuke and Amano, Toru and Okamoto, Tadao
European journal of pharmacology, ISSN 0014-2999, 05/2018, Volume 826, pp. 31 - 38
Systemic exposure | Calcemic effect | Vitamin D receptor target gene | Skin atrophy | Psoriasis | Vitamin D3-containing ointment | Vitamin D | containing ointment | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Rats, Wistar | Calcium - metabolism | Imiquimod | Humans | Calcitriol - adverse effects | Aminoquinolines - toxicity | Male | Administration, Cutaneous | Dermatologic Agents - adverse effects | Calcitriol - analogs & derivatives | Calcium - blood | Rats, Hairless | Hypercalcemia - blood | Betamethasone - adverse effects | Psoriasis - blood | Ointments | Skin - pathology | Disease Models, Animal | Psoriasis - drug therapy | Betamethasone - analogs & derivatives | Rats | Hypercalcemia - chemically induced | Receptors, Calcitriol - metabolism | Animals | Dihydroxycholecalciferols - adverse effects | Psoriasis - chemically induced | Atrophy - blood | Atrophy - chemically induced | Clobetasol - adverse effects | Drug Combinations | Skin - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
by Wang, Y and Jiang, T and Qin, Z and Jiang, J and Wang, Q and Yang, S and Rivard, C and Gao, G and Ng, T L and Tu, M M and Yu, H and Ji, H and Zhou, C and Ren, S and Zhang, J and Bunn, P and Doebele, R C and Camidge, D R and Hirsch, F R
Annals of oncology, ISSN 0923-7534, 03/2019, Volume 30, Issue 3, pp. 447 - 455
Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Aminoquinolines - administration & dosage | ErbB Receptors - genetics | Male | Protein Kinase Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Receptor, ErbB-2 - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - pathology | Afatinib - administration & dosage | ErbB Receptors - antagonists & inhibitors | Organoids - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Mutation - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Acrylamides - administration & dosage | Organoids - drug effects | Cell Line, Tumor | Aged | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Acrylamides - adverse effects | Aminoquinolines - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis
by Zanvit, Peter and Konkel, Joanne E and Jiao, Xue and Kasagi, Shimpei and Zhang, Dunfang and Wu, Ruiqing and Chia, Cheryl and Ajami, Nadim J and Smith, Daniel P and Petrosino, Joseph F and Abbatiello, Brittany and Nakatsukasa, Hiroko and Chen, Qianming and Belkaid, Yasmine and Chen, Zi-Jiang and Chen, Wanjun
Nature communications, ISSN 2041-1723, 09/2015, Volume 6, Issue 1, pp. 8424 - 8424
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Animals, Newborn | Disease Susceptibility | Psoriasis - drug therapy | Imiquimod | Polymyxin B - adverse effects | Mice, Inbred C57BL | Microbiota - drug effects | Interleukins - metabolism | Vancomycin - adverse effects | Interleukin-17 - metabolism | Animals | Drug Interactions | T-Lymphocytes - metabolism | Psoriasis - chemically induced | Psoriasis - metabolism | Anti-Bacterial Agents - adverse effects | Mice | Aminoquinolines | Skin - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Adverse effects of Aldara (R): Polymorphous erythema and chronic ulceration
by Schmutz, J. -L
Annales de dermatologie et de vénéréologie, ISSN 0151-9638, 01/2015, Volume 142, Issue 1, pp. 78 - 79
Life Sciences & Biomedicine | Dermatology | Science & Technology | Erythema - chemically induced | Skin Ulcer - chemically induced | Antineoplastic Agents - adverse effects | Humans | Aminoquinolines - adverse effects
Journal Article
Details down arrow
9. Full Text Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy
by Johnson, Douglas B and Wallender, Erika K and Cohen, Daniel N and Likhari, Sunaina S and Zwerner, Jeffrey P and Powers, Jennifer G and Shinn, Lisa and Kelley, Mark C and Joseph, Richard W and Sosman, Jeffrey A
Cancer immunology research, ISSN 2326-6066, 12/2013, Volume 1, Issue 6, pp. 373 - 377
vemurafenib | anti-PD-1 | immunotherapy | Melanoma | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Drug Eruptions - etiology | Guillain-Barre Syndrome - chemically induced | Skin Neoplasms - drug therapy | Humans | Middle Aged | Aminoquinolines - administration & dosage | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Indoles - administration & dosage | Indoles - adverse effects | Anaphylaxis - chemically induced | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Melanoma - drug therapy | Sulfonamides - adverse effects | Adult | Female | Sulfonamides - administration & dosage | Aminoquinolines - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
by Llanos-Cuentas, Alejandro and Lacerda, Marcus V.G and Hien, Tran T and Vélez, Iván D and Namaik-larp, Chayadol and Chu, Cindy S and Villegas, Maria F and Val, Fernando and Monteiro, Wuelton M and Brito, Marcelo A.M and Costa, Mônica R.F and Chuquiyauri, Raul and Casapía, Martín and Nguyen, Chau H and Aruachan, Sandra and Papwijitsil, Ratchadaporn and Nosten, François H and Bancone, Germana and Angus, Brian and Duparc, Stephan and Craig, Graham and Rousell, Victoria M and Jones, Siôn W and Hardaker, Elizabeth and Clover, Donna D and Kendall, Lindsay and Mohamed, Khadeeja and Koh, Gavin C.K.W and Wilches, Viviana M and Breton, John J and Green, Justin A
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 3, pp. 229 - 241
Prospective Studies | Humans | Aminoquinolines - administration & dosage | Male | Parasitemia - drug therapy | Secondary Prevention - methods | Primaquine - administration & dosage | Malaria, Vivax - complications | Adult | Female | Drug Therapy, Combination | Antimalarials - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Chloroquine - therapeutic use | Glucosephosphate Dehydrogenase Deficiency - complications | Disease-Free Survival | Antimalarials - administration & dosage | Malaria, Vivax - drug therapy | Adolescent | Plasmodium vivax - isolation & purification | Glucosephosphate Dehydrogenase - metabolism | Primaquine - adverse effects | Hemoglobins - analysis | Aminoquinolines - adverse effects | Tafenoquine | Prevention | Plasmodium vivax | Malaria | Primaquine | Analysis | Clinical trials | Hemoglobin | Dosage and administration | Research | Comparative analysis | Drug therapy | Health care | Enzymes | Chloroquine | Patients | Disease prevention | Glucose dehydrogenase | Enzymatic activity | Product development | Glucosephosphate dehydrogenase | Parasitemia | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights